Crowd Reviews Partnered with Pulsus to Announce: Unleash the
Enigma in Cardiology/ Heart Diseases through Heart
Congress 2020
Pulsus Group hosts the 34th World Congress on Heart Diseases (Heart
Congress 2020) that discusses the new paradigm approach to probe every single
element in Cardiology/ Heart Disease. Heart Congress 2020 focuses on many
interactive scientific sessions on different types of Blood disorders and
Cancers as well as various diagnostic and therapeutic advancements in this
field. It also provides an opportunity to showcase your ingenuity to the world.
Heart Congress 2020 will be organized around the theme “Renovation to Modulate the
pulse that beats for your life” on July 27- 28, 2020 at Madrid, Spain.
The major focus on the
Conference includes about new mechanisms for targeting specific Proteins in
Blood Stream, Latest uses of Heart Cells in Medicine, Advances in Hematology/
Cardiology, Emerging trends in Stem Cell research, Advancements in Diagnostic
& Therapeutic areas of Cardiology, Future directions in Pediatric
Cardiology/ Heart Diseases and many more.
The attendees of the Congress
will enjoy special events and lectures featuring expertise in the field. It is
a perfect platform for Cardiologists, Cardiac Surgeons, immunologists,
pathologists, research scholars, University Professors, industrial
professionals and student delegates from biomedical and healthcare sectors to explore
every single element in Cardiology/ Heart Diseases. Heart Congress 2020 will
also provide an excellent opportunity for the budding scientists and young
researchers through its special initiatives like Young Researcher Forum, Poster
Presentation, B2B and Scientific Meetings.
All the papers to be presented
in Heart Congress 2020 will
be published in Clinical Cardiology Journal, Current Research: Cardiology,
Journal of Cardiology and Clinical Therapeutics.
Conference Highlights:
Statistics:
· Only 45% of the global blood
supply is collected in developing countries, which are home to more than 80% of
the world’s population.
· 41 out of 148 countries
(28%) that provided data on screening for transfusion-transmissible infections
including HIV, hepatitis B and C, and syphilis were not able to screen all
donated blood for one or more of these infections.
·Heart
Failure is often considered a disease of affluence, but about
70% of Heart
Diseases deaths occur in low- and middle-income countries.
· A 2012 study in The Lancet
Cardiology predicted that from 2008-2030, Heart Diseases incidence will rise 75
percent globally and will double in the least developed countries.
· Sickle cell disease (SCD)
affects millions of people throughout the world and is particularly common
among those whose ancestors came from sub-Saharan Africa; Spanish-speaking
regions in the Western Hemisphere (South America, the Caribbean, and Central
America); Saudi Arabia; India; and Mediterranean countries such as Turkey,
Greece, and Italy.
· Hemophilia A affects 1 in
5,000 male births. About 400 babies are born with hemophilia A each year.
If you are interested to know
more about the Congress,
Contact: Emma Parker
Tel.: +44-203-769-1778
Email: cardionheart@gmail.com,
heartcongress@meetingsnexpo.com
